Galantamine in the Treatment of Post-Traumatic Headache

Status unconfirmed · Phase 4

Conditions studied: Post-Traumatic Headache, Head Trauma,Closed, Retention Disorders,Cognitive

In brief

Most patients with CPTH present with additional major cognitive, behavioral and somatic problems. Most drugs used currently have a negative influence on cognition. Therefore, treatment strategies addressing both the headache and cognitive disturbances in patients with CPTH are necessary. (CPTH; Chronic Post Traumatic Headache).

Key facts

Study ID

NCT00219869

Run by

Rapoport, Alan, M.D.

People needed

30

Starts

2005-07-01

Expected to finish

2005-08-01

Last updated by the study team

2005-09-22

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age range 18-75 CPTH according to ICHD-2 Fertile woman using adequate birth control Willing and able to give informed consent Willing and able to complete the entire course of the study to comply with study instructions Stable does of preventive medication

You may not qualify if…

• Subject is pregnant or lactating Significant medical or psychiatric disease Previous failure to 4 or more adequate trials of preventive medication Patient on non-stable dose of medication used to prevent CPTH

Where it is running

• The New England Center for Headache — Stamford, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.